Skip to content
PaperFren

Protein trafficking

Do cancer cells sort miRNAs into different EV types?

Temoche-Diaz MM, Shurtleff MJ, Nottingham RM, et al. · eLife · 2019

Open access · cc by · source: Europe PMC

Two MDA-MB-231 small-EV densities used selective vs non-selective miRNA loading; Lupus La and miR-122 motifs drove selective packaging.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.

Study at a glance

Design
Animal / in-vitro — Density fractionation of MDA-MB-231 sEVs; biochemical/genetic tests of miRNA sorting via Lupus La
N
N=2 · Two resolved small-EV density subpopulations (vLD and vHD)
Population
Metastatic breast cancer cell line–derived small extracellular vesicles
Outcome
Distinct selective vs non-selective miRNA sorting mechanisms; Lupus La/miR-122 motifs

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Do cancer cells sort miRNAs into different EV types?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

vLD density 1.09–1.11 g/ml; vHD 1.14–1.16 g/ml.

sEVs with a density ranging from 1.09 to 1.11 g/ml (vLD) may originate in the plasma membrane, whereas the sEVs with a density ranging from 1.14 to 1.16 g/ml (vHD) are more characteristic of exosomes

Two miR-122 motifs for La binding/sorting.

We found that two motifs embedded in miR-122 are responsible for high-affinity binding to Lupus La and sorting into vesicles formed in a cell-free reaction.
Read passages in the original paper

Key findings

Distinct sorting modes by EV subtype; Lupus La mediates selective miRNAs; two miR-122 motifs enable high-affinity La binding and vesicle sorting.

Methodology

Separated vLD (~1.09–1.11 g/ml) and vHD (~1.14–1.16 g/ml) sEVs and used biochemical/genetic tools plus cell-free packing assays.

Limitations

Cell-line mechanism does not prove in-patient metastasis causation for these sorting routes.

Related papers in this topic

Same topic cluster — not a recommendation engine.